A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...

New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

People with multimorbidity, defined as two or more long‐term conditions occurring within the same patient at the same time, ...

One of the main proteins that contributes to Alzheimer's disease is called phospho-tau (p-tau). When p-tau gets too many ...

A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A new experimental drug from ...

A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...

A tiny percentage of our DNA—around 2%—contains 20,000-odd genes. The remaining 98%—long known as the non-coding genome, or ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Consuming more high-fat cheese and high-fat cream might be linked to a lower risk of dementia in seniors, researchers suggest ...